Schweigerer L, Ledoux D, Fleischmann G, Barritault D
Sektion Onkologie/Immunologie, Universitäts-Kinderklinik, Ruprecht-Karls-Universität, Heidelberg, FRG.
Biochem Biophys Res Commun. 1991 Sep 30;179(3):1449-54. doi: 10.1016/0006-291x(91)91735-u.
We have examined the effect of human basic fibroblast growth factor (bFGF) on the proliferation of human neuroblastoma cells with normal and enhanced MYCN oncogene expression. bFGF stimulated the proliferation of the neuroblastoma cells with enhanced, but not normal, MYCN expression. Both cell species express FGFR-1, but not FGFR-2, receptors and both harbor FGF receptor species of Mr 145.000, but they differ in their pattern of lower and higher-molecular weight FGF receptor species. Our results demonstrate that enhanced MYCN expression confers to neuroblastoma cells the ability to respond to bFGF, possibly by inducing functional FGF receptors. This mechanism may contribute to the advanced malignant phenotype of human neuroblastomas with enhanced MYCN expression.
我们研究了人碱性成纤维细胞生长因子(bFGF)对具有正常和增强型MYCN癌基因表达的人神经母细胞瘤细胞增殖的影响。bFGF刺激了具有增强型而非正常型MYCN表达的神经母细胞瘤细胞的增殖。两种细胞类型均表达FGFR-1受体,但不表达FGFR-2受体,且都含有分子量为145,000的FGF受体类型,但它们在低分子量和高分子量FGF受体类型的模式上有所不同。我们的结果表明,增强的MYCN表达赋予神经母细胞瘤细胞对bFGF作出反应的能力,可能是通过诱导功能性FGF受体实现的。这一机制可能有助于具有增强型MYCN表达的人神经母细胞瘤的晚期恶性表型。